Subbu Nambi

Work Performance Price Targets & Ratings Chart

Analyst Subbu Nambi, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 67.27% that have a potential upside of 26.31% achieved within 150 days.

Subbu Nambi’s has documented 125 price targets and ratings displayed on 16 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on DHR, Danaher at 22-Jul-2026.

Wall Street Analyst Subbu Nambi

Analyst best performing recommendations are on CAI (CAI INTERNATIONAL).
The best stock recommendation documented was for CAI (CAI INTERNATIONAL) at 8/13/2025. The price target of $36 was fulfilled within 1 day with a profit of $1.72 (5.02%) receiving and performance score of 50.18.

Average potential price target upside

of $27.98 (18.72%) on NTRA (NATERA).
of $24.79 (23.94%) on ILMN (ILLUMINA).
of $18.28 (34.96%) on TEM (TEMPUS AI, COMMON STOCK).

ADPT Adaptive Biotechnologies Corp BRKR Bruker CAI CAI International CSTL Castle Biosciences DHR Danaher EXAS EXACT Sciences GH Guardant Health ILMN Illumina NAUT Nautilus Biotechnology NEOG Neogen NTRA Natera PSNL Personalis SOPH Sophia Genetics SA TEM Tempus AI, Common Stock TWST Twist Bioscience Corp VCYT Veracyte

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Tejas Savant (MORGAN STANLEY)